My Research – Session 2: Adherence Interventions

Session 2 (Wednesday 24th February at 7pm GMT) –  CLICK HERE to REGISTER

 

We would like to invite you to join our monthly ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend 10 minutes describing their career pathway and the next 10 minutes about the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

The second session will be delivered by: Nick Duncan and Andrea Preston

 

Biography (Nick Duncan) – Nick is an Academic Practitioner in the School of Pharmacy at the University of Birmingham and Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Foundation Trust, UK. He qualified as a pharmacist in 1994 and has spent most of his career to date working in oncology and haematology, particularly in the area of haematopoietic stem cell transplantation. He qualified as an independent prescriber in 2010 and has an active prescribing role in a variety of haematology clinics. Areas of research interest include medicines adherence, chronic myeloid leukaemia and antifungal stewardship.

 

 

 

 

Biography (Andrea Preston) – Andrea is the Divisional Lead Pharmacist for Haematology at University Hospitals Bristol NHS Foundation Trust and part time Cancer Commissioning Pharmacist for NHSE South. She studied pharmacy at Cardiff University and qualified in 1999. The majority of her career has been in cancer services. In her clinical role she is proud to work within an excellent team of cancer pharmacists delivering specialist pharmacy services to oncology and haematology including BMT and CAR-T. She is an independent prescriber in multiple myeloma and amyloidosis. Her special interest in pharmacy research started after completing an MSc in Clinical Oncology at University of Birmingham, where she met and started collaborating with Nick Duncan. Special areas of research interest include dosing of systemic anticancer therapy (SACT) in obesity, adherence and use of technology to improve safety of SACT.

 

 

 

 

 

 

Please Note:

 

-Webinars will start at 19:00 GMT and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day before the event

-Webinars are FREE to access for BOPA Paid Members

-Webinars will be recorded and appear in the BOPA eLearning section of the website via this link: https://www.bopa.org.uk/course-category/audit-and-research/

-Webinars will be on a monthly basis

 

Pinkie, Bastiaan and Alkesh
BOPA Audit & Research and Education &Training Sub-Committee Chairs

 

Latest News

By UK SACT Protocols Pilot Team on 20th November 2026

Have Your Say: Review the First UK SACT Protocol and Provide Feedback

Dear Colleagues working in cancer services We are writing to invite you to review and provide feedback on the first protocol produced as part of the UK SACT Protocols Pilot.…

Read article
By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article